ABSTRACT
Objective:
We aimed to compare the demographics, awareness about glaucoma, and adherence to the treatment between the young and old population of primary open angle glaucoma (POAG) patients.
Methods:
The POAG patients who were under follow-up in Bakırköy Training and Research Hospital Ophthalmology Clinic and were using medication since at least one year and volunteered for our survey were included this cross-sectional study between April and May 2018. Two surveys which included 13 questions and were used in previous studies were enriched with 6 additional questions and applied to the patients. The patients were divided into two groups according to the World Health Organization’s classification in regard to age as ≤65 years (young patients) and >65 years (old patients) and compared in regards to the survey questions.
Results:
There was not statistically significant between the two groups in regards to gender, general awareness about glaucoma, regular follow-up, regular drug use, family history of glaucoma, disability in hand and arm movements, duration of glaucoma (p>0.05 for all). There was a statistical difference between the two groups in regards to the education level (the patients ≤65 years were more educated, p=0.03), awareness of blindness secondary to the disease (more frequent in the patients ≤65 years old, p=0.02), awareness of drug’s brand (more frequent in the patients ≤65 years old, p=0.003), requiring assistance while using the drugs (more frequent in the group of patients >65 years-old, p=0.01), monthly number of forgetting the drug doses (more frequent in the group of patients >65 years-old, p=0.006), living alone (more frequent in the group of patients >65 years-old, p=0.02), and the number of used drugs (more frequent in the group of patients >65 years-old, p=0.03).
Conclusion:
It is obvious that the patients who are >65 years old will be less adherent to glaucoma treatment as they more frequently require assistance for drug use and live alone.
Keywords:
Glaucoma, drug, adherence
References
1Yüzbaşıoğlu E, Tuğcu B, Yıldırım H, Karahasanoğlu A, Yirik G. Topikal Glokom Tedavisinin Oküler Kan Akımı Üzerine Etkileri. Bakırköy Tıp Dergisi 2008;4:111-4.
2Cankaya AB. Glokom Tedavisine Uyum ve Bağlılık. Glo-Kat 2010;5:127-33.
3Doğanay S, Çankaya C. Glokom İlaçlarının Gelişimi ve İlaç Tedavi Prensipleri. Glo-Kat 2010;5:179-85.
4Alkin Z, Satana B, Ozkaya A, Basarir B, Altan C, Yazici AT, et al. Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study. Biomed Res Int 2014;2014:469163.
5Şimşek A, Bilgin B, Bilak Ş, Karadağ AS. Glokom Hastalarının Tedaviye Olan Uyum ve Farkındalığında Eğitim Düzeyinin Önemi. Turkiye Klinikleri J Ophthalmol 2016;25:78-82.
6Çankaya AB, İşlek E, Şimşek T, Özdamar Y, Zilelioğlu O. Glokom Hastalarının Tedaviye Uyum ve Bağlılıklarını Etkileyen Faktörlerin İncelenmesi. Turk J Ophthalmol 2010;40:199-204.
7Eren MH, Altan Ç, Akagündüz U, Bayraktar Ş, Yılmaz ÖF. Glokomun Medikal Tedavisinde Hasta Uyumu. Glo-Kat 2008;3:158-64.
8Robin A, Grover DS. Compliance and adherence in glaucoma management. Indian J Ophthalmol 2011;59 Suppl 1:S93-6.
9Dreer LE, Girkin C, Mansberger SL. Determinants of Medication Adherence to Topical Glaucoma Therapy. J Glaucoma 2012;21:234–40.
10Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. Patterns of adherence behaviour for patients with glaucoma. Eye (Lond) 2013;27:545-53.
11Gatwwod JD, Johnson J, Jerkins B. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study. J Glaucoma 2017;26:1056-61.
12Atey TM, Shibeshi W, Giorgis AT, Asgedom SW. The Impact of Adherence and Instillation Proficiency of Topical Glaucoma Medications on Intraocular Pressure. J Ophthalmol 2017;2017:1683430.
13Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol 2016;16:131.
14Loon SC, Jin J, Jin Goh M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma 2015;24:e36-42.
15Olthoff CM, Hoevenaars JG, van den Borne BW, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2009;247:235-43.
16Rees G, Leong O, Crowston JG, Lamoureux EL. Intentional and unintentional non adherence to ocular hypotensive treatment in patients with glaucoma. Ophthalmology 2010;117:903-8.
17Vélez-Gómez MC, Vásquez-Trespalacios EM. Adherence to topical treatment of glaucoma, risk and protective factors: A review. Arch Soc Esp Oftalmol 2018;93:87-92.
18Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol 2008;53 Suppl1:S57-68.
